Genenta Science Company Insiders
GNTA Stock | USD 4.69 0.11 2.29% |
Genenta Science employs about 14 people. The company is managed by 8 executives with a total tenure of roughly 33 years, averaging almost 4.0 years of service per executive, having 1.75 employees per reported executive. Analysis of Genenta Science's management performance can provide insight into the company performance.
Genenta |
Genenta Science Management Team Effectiveness
The company has return on total asset (ROA) of (0.2583) % which means that it has lost $0.2583 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4289) %, meaning that it created substantial loss on money invested by shareholders. Genenta Science's management efficiency ratios could be used to measure how well Genenta Science manages its routine affairs as well as how well it operates its assets and liabilities. As of November 23, 2024, Return On Tangible Assets is expected to decline to -0.55. In addition to that, Return On Capital Employed is expected to decline to -0.6. At present, Genenta Science's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 1.3 M, whereas Net Tangible Assets are forecasted to decline to about 13.6 M.The current year's Common Stock Shares Outstanding is expected to grow to about 20 M, whereas Net Loss is forecasted to decline to (5.3 M).
Genenta Science Workforce Comparison
Genenta Science SpA is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,202. Genenta Science claims roughly 14.0 in number of employees contributing just under 2% to equities under Health Care industry.
Genenta Science Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Genenta Science insiders, such as employees or executives, is commonly permitted as long as it does not rely on Genenta Science's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Genenta Science insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Rosenwald Lindsay A Md over six months ago Disposition of 64562 shares by Rosenwald Lindsay A Md of Genenta Science subject to Rule 16b-3 | ||
Rosenwald Lindsay A Md over six months ago Disposition of 2287 shares by Rosenwald Lindsay A Md of Genenta Science subject to Rule 16b-3 |
Genenta Science Notable Stakeholders
A Genenta Science stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Genenta Science often face trade-offs trying to please all of them. Genenta Science's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Genenta Science's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Pierluigi Paracchi | Chairman CoFounder | Profile | |
Stefania Mazzoleni | Director Development | Profile | |
Barbara Regonini | Director Finance | Profile | |
Carlo MD | Chief Development | Profile | |
Richard Slansky | Chief Officer | Profile | |
Tim Obara | Head Devel | Profile | |
Luigi MD | CoFounder Board | Profile | |
Bernard MD | CoFounder Board | Profile |
About Genenta Science Management Performance
The success or failure of an entity such as Genenta Science SpA often depends on how effective the management is. Genenta Science management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genenta management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genenta management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.52) | (0.55) | |
Return On Capital Employed | (0.57) | (0.60) | |
Return On Assets | (0.52) | (0.55) | |
Return On Equity | (0.57) | (0.60) |
Please note, the presentation of Genenta Science's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Genenta Science's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Genenta Science's management manipulating its earnings.
Genenta Science Workforce Analysis
Traditionally, organizations such as Genenta Science use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genenta Science within its industry.Genenta Science Manpower Efficiency
Return on Genenta Science Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 831.8K | |
Net Loss Per Executive | 1.5M | |
Working Capital Per Employee | 1.4M | |
Working Capital Per Executive | 2.4M |
Complementary Tools for Genenta Stock analysis
When running Genenta Science's price analysis, check to measure Genenta Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genenta Science is operating at the current time. Most of Genenta Science's value examination focuses on studying past and present price action to predict the probability of Genenta Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genenta Science's price. Additionally, you may evaluate how the addition of Genenta Science to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Stocks Directory Find actively traded stocks across global markets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |